DSM N.V. : Final dividend Royal DSM

                     DSM N.V. : Final dividend Royal DSM

The DSM Annual General Meeting of Shareholders on 3 May 2013 passed a
resolution to declare a dividend for 2012 of €1.50 per ordinary share of €1.50
par value. An interim dividend of €0.48 per ordinary share having been paid on
30 August 2012, the final dividend for 2012 will amount to €1.02 per ordinary
share. With the passing of the resolution by the AGM, and in line with DSM's
policy to provide a stable and preferably rising dividend, 2012 marks the
third consecutive year DSM's dividend has been increased.

This final dividend of €1.02 will be paid out in cash or in the form of
ordinary shares at the option of the shareholder. Dividend in cash will be
paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend
date on NYSE Euronext will be 7 May 2013 and the record date will be 9 May
2013.

Shareholders have from 10 May until 24 May 2013 (3.00 pm CET) to indicate
their choice. On 27 May 2013 after the close of trading on NYSE Euronext the
number of dividend rights of ordinary shares entitling the holder to one
ordinary share will be determined.

This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at NYSE Euronext on 20 May 2013 up to and
including 24 May 2013. The value of the stock dividend will be virtually equal
to the value of the cash dividend. The ordinary shares that constitute the
stock dividend are entitled to any dividend for the financial year 2013 and to
the dividends for subsequent financial years. Stock dividend rights will not
be traded on NYSE Euronext.

The following timetable applies:
7 May 2013:                 Ex-dividend
quotation
9 May 2013:Record Date
10 May 2013 - 24 May 2013(3.00 pm CET):     Period in which shareholders
can indicate their choice
27 May 2013 (COB):            Announcement of
the exchange ratio
29 May 2013:                Delivery of
shares or cash payment

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
DSM's 23,500 employees deliver annual net sales of around €9 billion. The
company is listed on NYSE Euronext.
More information can be found at www.dsm.com.

Or find us on: [IMG] [IMG] [IMG] [IMG]

For more information:

DSM Corporate Communications   DSM Investor Relations

Herman Betten                  Dave Huizing
tel. +31 (0) 45 5782017      tel. +31 (0) 45 5782864
e-mail media.relations@dsm.com e-mail investor.relations@dsm.com

Press release-pdf

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: DSM N.V. via Thomson Reuters ONE
HUG#1699045
 
Press spacebar to pause and continue. Press esc to stop.